Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico.
Study Design
- Type d'étude
- Case Reports
- Taille de l'échantillon
- 3
- Population
- Patients with anxiety disorders in Mexico
- Intervention
- Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. None
- Comparateur
- None
- Critère de jugement principal
- Anxiety symptom improvement
- Direction de l'effet
- Positive
- Risque de biais
- High
Abstract
Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need arises to develop new pharmacological treatments for these patients. This paper has the primary objective of evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases.
En bref
Evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases is evaluated.
Used In Evidence Reviews
Similar Papers
Current psychiatry reports · 2017
Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Archives of internal medicine · 2007
Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials.
Pharmaceuticals (Basel, Switzerland) · 2012
Cannabidiol in humans-the quest for therapeutic targets.
Nutricion hospitalaria · 2015
NUTRITIONAL AND TOXICOLOGICAL ASPECTS OF SPIRULINA (ARTHROSPIRA).
CNS drugs · 2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
The Permanente journal · 2016